References

Brachytherapy

Guinot JL et al. Radiother Oncol. 2018; 126:377-85. Available at: https://doi.org/10.1016/j.radonc.2018.01.013 Accessed June 2021
Bussu F et al. Brachytherapy 2021; 20(1):178-84. Available at: https://doi.org/10.1016/j.brachy.2020.08.008 Accessed June 2021
Delishaj D et al. J Contemp Brachyther. 2016; 8(6):533-40. Available at: https://doi.org/10.5114/jcb.2016.64112 Accessed June 2021
Ouhib Z et al. Brachytherapy 2015; 14:840-58. Available at: https://doi.org/10.1016/j.brachy.2015.06.005 Accessed June 2021

National Cancer Institute. Available at: https://www.cancer.gov/types/skin/patient/skin-treatment-pdq#_59. Accessed June 2021 2.
Bichakjian CK et al. NCCN Clinical Practice in Oncology (NCCN Guidelines®) Basal Cell Skin Cancer 2016. Available at: https://jnccn. org/view/journals/jnccn/14/5/article-p574.xml Accessed June 2021
Guinot JL et al. Radiother Oncol. 2018; 126:377-85. Available at: https://doi.org/10.1016/j.radonc.2018.01.013 Accessed June 2021
Frakulli R et al. J Contemp Brachyther. 2015; 7(6):497-502. Available at: https://dx.doi.org/10.5114%2Fjcb.2015.56465 Accessed June 2021
Bussu F et al. Laryngoscope 2016; 126(2):367-71. Available at: https://doi.org/10.1002/lary.25498 Accessed June 2021 6. Newlands C et al. J Laryngol Otol. 2016: 130:S125-S132. Available at: https://doi.org/10.1017/S0022215116000554 Accessed May 2021
Drucker AM et al. Ann Intern Med. 2018; 169(7):456-66. Available at: https://doi.org/10.7326/m18-0678 Accessed June 2021
Altun E. et al. Dermatol Ther. 2021; 34(1):e14476. Available at: https://doi.org/10.1111/dth.14476 Accessed June 2021

Guinot JL et al. Radiother Oncol. 2018; 126:377-85. Available at: https://doi.org/10.1016/j.radonc.2018.01.013 Accessed June 2021
Bussu F. et al. Brachytherapy 2021; 20(1):178-84. Available at: https://doi.org/10.1016/j.brachy.2020.08.008 Accessed June 2021
Delishaj D et al. J Contemp Brachyther. 2016; 8(6):533-40. Available at: https://doi.org/10.5114/jcb.2016.64112 Accessed June 2021
Ouhib Z et al. Brachytherapy 2015; 14:840-58. Available at: https://doi.org/10.1016/j.brachy.2015.06.005 Accessed June 2021
Tormo A et al. J Contemp Brachyther. 2014; 6(2):167-172. Available at: https://dx.doi.org/10.5114%2Fjcb.2014.43247 Accessed June 2021
Gauden R et al. J Med Imaging Radiat Oncol. 2013; 57(2):212-7. Available at: https://doi.org/10.1111/j.1754-9485.2012.02466.x Accessed June 2021
Wang Y et al. Clin Plast Surg. 2009; 36(3):336-44. Available at: https://doi.org/10.1016/j.cps.2009.02.008 Accessed June 2021

1. Delishaj D et al. J Contemp Brachyther. 2016; 8(6):533-40. Available at: https://doi.org/10.5114/jcb.2016.64112 Accessed June 2021
Tormo A et al. J Contemp Brachyther. 2014; 6(2):167-172. Available at: https://dx.doi.org/10.5114%2Fjcb.2014.43247 Accessed June 2021
Gauden R et al. J Med Imaging Radiat Oncol. 2013; 57(2):212-7. Available at: https://doi.org/10.1111/j.1754-9485.2012.02466.x Accessed June 2021

Boston Scientific.
Mariados N, Sylvester J, Shah D, et al. Hydrogel spacer prospective multicenter randomized controlled pivotal trial: Dosimetric and clinical effects of perirectal spacer application in men undergoing prostate image guided intensity modulated radiation therapy. Int J Radiat Oncol Biol Phys. 2015;92:971–977.
Hamstra DA, Mariados N, Sylvester J, et al. Continued benefit to rectal separation for prostate radiation therapy: Final results of a phase III trial. Int J Radiat Oncol Biol Phys. 2017;97:976–985.
Hamstra DA, Mariados N, Sylvester J, et al. Sexual quality of life following prostate intensity modulated radiation therapy (IMRT) with a rectal/prostate spacer: Secondary analysis of a phase 3 trial. Pract Radiat Oncol. 2018;8:e7–e15.